Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $386K | ﹤0.01% |
+2,300
| New | +$361K |
|
|
AUD
2952
DELISTED
Audacy, Inc.
AUD
| $386K | ﹤0.01% |
279,533
-187,719
| -40% | -$266K |
|
2953
TRX Gold Corp
TRX
$341M
| $385K | ﹤0.01% |
+435,500
| New | +$302K |
|
2954
Sonic Automotive
SAH
$2.56B
| $384K | ﹤0.01% |
12,026
-98,992
| -89% | -$2.28M |
|
|
DYNT
2955
DELISTED
Dynatronics Corp
DYNT
| $384K | ﹤0.01% |
87,173
+27,733
| +47% | +$110K |
|
2956
Solid Biosciences
SLDB
$972M
| $382K | ﹤0.01% |
8,700
+2,930
| +51% | +$122K |
|
|
SPN
2957
DELISTED
Superior Energy Services, Inc.
SPN
| $382K | ﹤0.01% |
335,282
+269,040
| +406% | +$369K |
|
|
AIFU
2958
AIFU Inc
AIFU
$218M
| $380K | ﹤0.01% |
+48
| New | +$378K |
|
|
ACRE
2959
Ares Commercial Real Estate
ACRE
$261M
| $379K | ﹤0.01% |
+41,600
| New | +$324K |
|
2960
Soligenix
SNGX
$8.29M
| $379K | ﹤0.01% |
748
-1,465
| -66% | -$604K |
|
2961
iShares MSCI Switzerland ETF
EWL
$2.22B
| $378K | ﹤0.01% |
+9,700
| New | +$364K |
|
|
MFNC
2962
DELISTED
Mackinac Financial Corporation
MFNC
| $377K | ﹤0.01% |
36,368
-27,600
| -43% | -$273K |
|
2963
Comstock Holding Companies
CHCI
$152M
| $376K | ﹤0.01% |
134,916
+38,432
| +40% | +$81.9K |
|
|
NINE
2964
DELISTED
Nine Energy Service
NINE
| $376K | ﹤0.01% |
192,900
+32,200
| +20% | +$54.1K |
|
2965
Sol-Gel Technologies
SLGL
$234M
| $376K | ﹤0.01% |
4,199
+1,114
| +36% | +$90.1K |
|
2966
Daxor
DXR
$59.5M
| $374K | ﹤0.01% |
25,521
+11,820
| +86% | +$168K |
|
|
BNSO
2967
DELISTED
Bonso Electronic International
BNSO
| $374K | ﹤0.01% |
142,800
+2,400
| +2% | +$5.51K |
|
|
EEX
2968
DELISTED
Emerald Holding
EEX
| $373K | ﹤0.01% |
120,957
-371,800
| -75% | -$883K |
|
2969
Galmed Pharmaceuticals
GLMD
$4.63M
| $373K | ﹤0.01% |
433
+210
| +94% | +$177K |
|
|
RELV
2970
DELISTED
Reliv International Inc
RELV
| $373K | ﹤0.01% |
103,680
-3,100
| -3% | -$10.7K |
|
|
SALM
2971
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $372K | ﹤0.01% |
329,398
+54,500
| +20% | +$51.9K |
|
2972
Celcuity
CELC
$4.49B
| $371K | ﹤0.01% |
53,500
-7,960
| -13% | -$55.9K |
|
|
ELSE
2973
DELISTED
Electro-Sensors
ELSE
| $371K | ﹤0.01% |
106,700
+1,900
| +2% | +$6.34K |
|
|
TSRI
2974
DELISTED
TSR Inc. New
TSRI
| $369K | ﹤0.01% |
77,650
+1,400
| +2% | +$5.04K |
|
2975
Radiant Logistics
RLGT
$400M
| $368K | ﹤0.01% |
93,700
+8,600
| +10% | +$33.2K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.